Literature DB >> 31029345

A chemo-photothermal synergetic antitumor drug delivery system: Gold nanoshell coated wedelolactone liposome.

Xuwu Zhang1, Yanping Liu1, Liyao Luo1, Lei Li1, Shanshan Xing1, Tian Yin1, Kexin Bian1, Ruiyan Zhu2, Dawei Gao3.   

Abstract

In this study, an antitumor drug delivery system, gold nanoshell coated wedelolactone liposomes (AuNS-Wed-Lip), were designed and synthesized. In the drug delivery system, wedelolactone liposome and gold-nanoshell were linked by l-cysteine, which had been shown an effective nanocarrier for antitumor drug delivery, on-demand drug release, and phototherapy under near-infrared (NIR) light irradiation. It was capable of absorbing 780-850 nm NIR light and converting light energy to heat rapidly. The hyperthermia promoted wedelolactone release rapidly from the systems. The release amount of AuNS-Wed-Lip under NIR irradiation reached up to 97.34% over 8 h, achieving the on-demand drug release. Moreover, a high inhibition rate up to 95.73% for 143B tumor cells by AuNS-Wed-Lip upon laser irradiation at 808 nm was observed. The excellent inhibition efficacy was also displayed in vivo antitumor study with S180 tumor-bearing mice. The results demonstrated that AuNS-Wed-Lip, as an antitumor drug delivery system, achieved chemo-photothermal synergetic effect, which has great potential in cancer therapy.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gold nanoshell; Near infrared; Photothermal therapy; Synergetic effect; Wedelolactone liposome

Mesh:

Substances:

Year:  2019        PMID: 31029345     DOI: 10.1016/j.msec.2019.04.006

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  2 in total

1.  Gefitinib encapsulation based on nano-liposomes for enhancing the curative effect of lung cancer.

Authors:  Yanjie Hu; Jisong Zhang; Huihui Hu; Shan Xu; Li Xu; Enguo Chen
Journal:  Cell Cycle       Date:  2020-12-10       Impact factor: 4.534

Review 2.  Gold nanoparticle‑mediated delivery of paclitaxel and nucleic acids for cancer therapy (Review).

Authors:  Zhiguang Wang; Jianyu Dong; Qiaojiajie Zhao; Ying Ying; Lijie Zhang; Junrong Zou; Shuqi Zhao; Jiuju Wang; Yuan Zhao; Shanshan Jiang
Journal:  Mol Med Rep       Date:  2020-10-11       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.